Company intelligence / Profile preview

Frontage Holdings

Exton, Pennsylvania, United States

Ownership: Private
Employees: ~1560
Development stage: Other

Overview

Frontage Holdings is a global contract research and development organization providing drug discovery, preclinical, clinical, and laboratory testing services for pharmaceutical, biotechnology, animal health, agrochemical, and chemical clients. Its offerings span from early discovery and IND-enabling studies to CMC, clinical trial management, and bioanalytical services. The company does not have its own drug pipeline but facilitates and accelerates clients' product development programs across multiple modalities and therapeutic areas.

Modalities: Small moleculeBiologicCell therapyGene therapy
Industry: Drug Discovery Services

Partnerships

NMS Group S.p.A. (Accelera acquisition)Multiple global pharmas and biotech partners (client base)

Beyond the preview

Go deeper on Frontage Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frontage Holdings.

Explore the full profile